Toggle Main Menu Toggle Search

Open Access padlockePrints

C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection

Lookup NU author(s): Dr Tevfik Dorak


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


We explored the influence of the major CCR5 promoter or coding region variants as haplotypes and genotypes in a cohort of 250 chronically infected HCV patients receiving combined interferon/ ribavirin therapy. No haplotype, including the D32-bearing haplotype (G*2) reportedly associated in homozygotes with high HCV viral load (VL), showed a similar effect. Patients with genotype C/G*2 showed slightly lower median VL (p = 0.05). Neither the G*2 haplotype nor the C/G*2 genotype influenced viral dynamics during the initial 12 wk of treatment (p = 0.53). The genotype E/E was more frequent among sustained responders (15.5%) than non-responders (7.8%), and VL declined further among E/E homozygotes during the initial 12 wk of treatment, particularly those with HCV genotype 1 (p = 0.016). Differential receptor expression due to E/E homozygosity in HCV infection remains to be confirmed.

Publication metadata

Author(s): Dorak MT; Folayan GO; Niwas S; van Leeuwen DJ; Yee LJ; Tang J; Kaslow RA

Publication type: Article

Publication status: Published

Journal: Immunologic Research

Year: 2002

Volume: 26

Issue: 1-3

Pages: 167-175

ISSN (print): 0257-277X

ISSN (electronic): 1559-0755

Publisher: Humana Press, Inc.


DOI: 10.1385/IR:26:1-3:167

PubMed id: 12403355


Altmetrics provided by Altmetric